Julio
Dávila Valls
Forscher in der Zeit 2015-2017
University Hospital Olomouc
Olomouc, República ChecaPublikationen in Zusammenarbeit mit Forschern von University Hospital Olomouc (7)
2024
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
-
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection
-
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Hematological Oncology, Vol. 42, Núm. 1
2023
-
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
International Journal of Infectious Diseases, Vol. 137, pp. 98-110
2022
-
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood, Vol. 140, Núm. 26, pp. 2773-2787
2016
-
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice
American Journal of Hematology, Vol. 91, Núm. 6, pp. 575-580
-
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Leukemia and Lymphoma, Vol. 57, Núm. 9, pp. 2071-2076